 |
Mark M. Moasser, MD
Dr. Moasser is a medical oncologist specializing in breast cancer treatment and research. He has both clinical and scientific backgrounds and is particularly interested in applying the rapidly accumulating wealth of knowledge about signaling pathways in tumor cells to the development of novel therapeutic agents and ultimately much more effective agents for the treatment of breast cancer. He has been investigating the signaling pathways by which certain proteins such as Her2 or src can cause cells to become malignant and how their malignant behavior can be reversed using designer drugs that specifically interfere with these signaling pathways. He has published his work in numerous scientific journals and regularly presents his findings at scientific meetings. Dr. Moasser graduated from Tufts University School of Medicine and completed his residency and fellowship training at The New York Hospital - Cornell Medical Center and Memorial Sloan-Kettering Cancer Center in New York. After serving a number of years on the faculty of the Breast Cancer Medicine Service of Memorial Sloan-Kettering he was recruited to the UCSF Breast Cancer Program where he continues his work with breast cancer patients and his efforts to develop more effective therapies for the treatment of breast cancer through translational scientific research and clinical trials. Dr. Moasser is a recipient of the American Society for Clinical Oncology Career Development Award and the American Cancer Society Research Scholar Award. He is an investigator of the National Institutes of Health, and a recipient of research awards from the Susan Komen Breast Cancer Foundation and the California Breast Cancer Research Program for his work related to breast cancer. Dr. Moasser has an avid interest in music, he is an accomplished pianist, a patron of the arts and can often be found at the symphony, opera, or area museums. He is also an amateur photographer and is also involved in numerous athletic pursuits. |